These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 33912155

  • 21. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 22. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug 27; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 23. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
    Sun Y, Liu J, Geng Z, Tao Y, Zheng F, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2020 Mar 17; 18(1):23. PubMed ID: 32183825
    [Abstract] [Full Text] [Related]

  • 24. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J, Oh JS, Yoon JM, Ko KO, Yoo GH, Cheon EJ.
    BMC Pediatr; 2022 Aug 05; 22(1):474. PubMed ID: 35931986
    [Abstract] [Full Text] [Related]

  • 25. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Aug 05; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 26. N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease.
    Rodriguez-Gonzalez M, Perez-Reviriego AA, Castellano-Martinez A, Cascales-Poyatos HM.
    Biomark Med; 2019 Mar 05; 13(4):307-323. PubMed ID: 30900472
    [Abstract] [Full Text] [Related]

  • 27. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 28. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L, Dionne A, Meloche-Dumas L, Fournier A, Dahdah N.
    Pediatr Cardiol; 2020 Jun 10; 41(5):947-954. PubMed ID: 32172336
    [Abstract] [Full Text] [Related]

  • 29. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
    Zhonghua Er Ke Za Zhi; 2006 May 10; 44(5):324-8. PubMed ID: 16780705
    [Abstract] [Full Text] [Related]

  • 30. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 May 10; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 31. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
    [Abstract] [Full Text] [Related]

  • 32. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep 02; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 33. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, Dallaire F, Cousineau J, Delvin E, Dahdah N.
    Pediatr Int; 2012 Oct 02; 54(5):627-33. PubMed ID: 22414326
    [Abstract] [Full Text] [Related]

  • 34. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
    Iwashima S, Ishikawa T.
    World J Pediatr; 2013 Aug 02; 9(3):239-44. PubMed ID: 23335186
    [Abstract] [Full Text] [Related]

  • 35. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 02; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 36. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y, Suda K, Nakaoka H, Katsube Y, Mitani Y, Yoshikane Y, Ichida F, Matsushita T, Shichino H, Shiraishi I, Abe J, Hiroe M, Yoshida T, Imanaka-Yoshida K.
    Circ J; 2016 Oct 25; 80(11):2376-2381. PubMed ID: 27746411
    [Abstract] [Full Text] [Related]

  • 37. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
    Song HB, Zhang YD, Dong QW, Han LP, Qi RF, Bi BB, Ma L, Ma L, Zhang H.
    J Coll Physicians Surg Pak; 2020 Jan 25; 30(1):37-40. PubMed ID: 31931930
    [Abstract] [Full Text] [Related]

  • 38. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, Zhang LY, Wu Q.
    Zhonghua Er Ke Za Zhi; 2005 Sep 25; 43(9):676-80. PubMed ID: 16191301
    [Abstract] [Full Text] [Related]

  • 39. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 25; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 40. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML, Manlhiot C, Collins TH, Chahal N, Yeung RSM, McCrindle BW.
    Int J Cardiol; 2017 Jun 01; 236():157-161. PubMed ID: 28089146
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.